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Introduction: During pregnancy, maternal stressors cause changes in both maternal and fetal 
HPA axes. We therefore investigated the impact of maternal acute and chronic stress on fetal 
glucose metabolism and growth, and serum levels of cortisol in the fetus. 
Materials and Methods: Normal weight pregnant women (n=192; mean±SD 27.94.2 years 
old, and; 26.9±2.4 kg/m²) were assessed during the 2nd and 3rd trimester with anthropometry, 
fetal ultrasound, blood samples for serum CRH, cortisol and IL6, and STAI trait and state 
stress questionnaires. We measured serum cortisol, insulin and c-peptide, and plasma glucose 
from cord blood. Neonates underwent anthropometry at the 3rd post-delivery day. 
Results: In both 2nd and 3rd trimesters, women with STAI trait scores ≥40 had significantly 
greater levels of fasting serum CRH and cortisol than those with STAI trait scores<40.  
2nd trimester: STAI trait scores correlated positively with cord blood glucose and c-peptide. 
Maternal serum CRH correlated negatively with U/S fetal biparietal head diameter, while 
serum cortisol correlated positively with abdominal circumference. Maternal serum IL6, CRH 
and cortisol all correlated positively with birth waist circumference.  
3rd trimester: Women with STAI state scores ≥40 had fetuses with larger U/S abdominal and 
smaller head circumferences compared to those of women with STAI scores <40. Women 
with STAI trait scores ≥40 had greater levels of cord blood cortisol, glucose, and c-peptide 
compared to women with STAI scores <40. STAI state scores ≥40 correlated positively with 
maternal CRH and U/S fetal abdominal circumference, and negatively with fetal head 
circumference and biparietal diameter. STAI trait scores correlated positively with cord blood 
c-peptide, glucose, insulin and cortisol. Maternal serum levels of CRH correlated positively 
with U/S fetal abdominal circumference and cord blood cortisol, and negatively with fetal 
head circumference and biparietal head diameter. Maternal serum levels of both CRH and 
cortisol correlated positively with cord blood c-peptide, glucose, and insulin. STAI trait was 
the best positive predictor of cord blood cortisol, glucose and c-peptide, whilst STAI state was 
the best positive and negative predictor, respectively of fetal abdominal circumference and  
fetal head circumference or biparietal diameter. 
Conclusions: Increased maternal chronic stress (reflected by the STAI trait score) associates 
with increased fetal cortisol, glucose, c-peptide secretion and thus, insulin resistance. 
Maternal acute stress (STAI state) in the 3rd trimester associates with changes in fetal growth 
pattern, including increased and decreased measurements of fetal abdominal and head growth 
respectively.   
1. Introduction  
 ‘‘Stress’’ is a state of disharmony or threat to homeostasis. The hypothalamic-
pituitary-adrenal (HPA) axis and the locus ceruleus–norepinephrine (LC/NE) autonomic 
systems are the main components of the endocrine response to stress (Croussos & Gold 
,1992). During pregnancy, a state of relative hypercortisolism ensues, with increased serum 
levels of CRH (secreted from the placenta) in the maternal circulation, especially during the 
3rd trimester (Magiakou et al., 1996). Placental CRH has been proposed as a potential 
predictor for preterm, term, or post-term labor (Mastorakos & Ilias, 2000 ). During pregnancy, 
chronic or acute maternal stressors may influence the function of both maternal and fetal HPA 
axes in the short-term, and offspring physiology in the long-term. In sheep, chronic 
psychosocial maternal stress during early gestation associates with increased levels of serum 
cortisol (both baseline and stress-induced) and norepinephrine in the fetus, indicating 
hyperactivity in the fetal HPA-axis and sympathetic-adrenal-medullary system (Bischoff et 
al., 2018). Premature activation of the fetal HPA axis may result from an adverse intra-uterine 
environment, such as hypoxemia. Excessive serum levels of glucocorticoids in the fetus due 
to sustained endogenous fetal cortisol production, associates with intrauterine growth 
restriction (Challis et al., 2001). 
 Insulin resistance is a feature of normal pregnancy, described as an adaptive 
phenomenon to divert maternal glucose towards fetal needs (Radaelli et al., 2003). We have 
shown previously in a cohort of normal pregnant women, that long-term stress (assessed 
through use of the STAI trait questionnaire) associates with decreased maternal insulin 
sensitivity (Valsamakis et al., 2017). Other studies in humans have shown that exposure of the 
mother to prenatal psychosocial stress associates with development of insulin resistance in the 
offspring, assessed during young adulthood (Etringer et al., 2008). Similar studies in rats have 
shown that maternal exposure to prenatal stress associates with induction of intrauterine 
growth restriction (IUGR) and glucose intolerance (Lesage et al., 2004). Furthermore, chronic 
heat stress in maternal ewes induced a shift towards glucose metabolism within the fetal liver, 
which as the authors stated, could be explained by stress- and cortisol-induced increased 
activity of gluconeogenic enzymes within the fetal liver (Dreilling et al., 1991).  
 Low birth weight (LBW), prematurity and IUGR remain leading causes of perinatal 
morbidity, mortality, neurodevelopmental impairments and disabilities among newborn 
babies (WHO, 1995). Placental CRH, cortisol and other hormones that cross the placenta, 
could result in retardation of fetal growth rate, reduced birth weight and precipitation of 
preterm labor in prenatally stressed fetuses (Weinstock, 2005 ). Animal studies confirmed that 
increased serum levels of stress hormones and pro-inflammatory cytokines in the fetal 
compartment during sensitive or critical developmental windows, can have an impact on the  
structure and function of the brain and peripheral targets that are related to body composition, 
energy balance homeostasis and metabolic function (i.e., adipose tissue, pancreas, and liver) 
(Raternain, 2013; Lesage, 2004). Current evidence suggests that maternal stress experienced 
early in gestation, has more serious consequences for the offspring than stress experienced 
later in gestation (Mueller & Bale, 2007).   
 STAI is a well-standardized, self-reported questionnaire designed to measure both 
‘state’ and ‘trait’ anxiety. Feelings of anxiety may occur in stressful situations. State anxiety 
refers to fear, nervousness, discomfort, and arousal of the autonomic nervous system, all 
induced temporarily by situations perceived as dangerous (i.e., how a person is feeling at the 
time of a perceived threat). Conversely, trait anxiety refers to a relatively enduring 
predisposition to feelings of stress, worry, and discomfort (Sielberger & Sydeman, 1994). 
Within the literature, there is good establishment and usage of the STAI trait and state 
questionnaire for use in pregnancy for the purpose of assessment of maternal stress (Rondo et 
al., 2003; Di Pietro et al., 2006). However, to date there is insufficient data regarding the 
impact of duration of maternal stress (acute vs long-term) on fetal growth and/or metabolism. 
To address this, we investigated the impact of maternal acute and chronic stress (evaluated by 
STAI state and trait questionnaires and maternal serum levels of CRH, cortisol, and IL6) on 
serum levels of cortisol, glucose metabolism and growth pattern within the fetus. 
2. Materials and Methods 
2.1.  Subjects 
 Primigravidae caucasian women (n=220) were recruited during the first trimester of 
pregnancy from an antenatal outpatient clinic of a university hospital in Greece, between May 
2015 and December 2017. To avoid bias, we used a computer software random numbers 
generator for recruitment purposes. Women who presented with miscarriages during the first 
trimester of pregnancy (n=12) were not included in the protocol. Following psychiatric 
assessment during the first trimester, women with past or current severe mental health 
problems such as severe depression or anxiety (n=8) were excluded from the study. 
Accordingly, n=200 women were included in the study protocol (age, mean±SD: 28.24.5 
years; pre-pregnancy BMI: 27.1±2.6 kg/m²). Following recruitment, initiation of execution of 
the study occurred during the 2nd trimester of pregnancy. Exclusion criteria included: 
 Non-caucasian origin (to maintain population homogeneity regarding insulin 
resistance traits) 
 Pre-pregnancy BMI>30 kg/m2 
 History of type 1 or type 2 diabetes mellitus or glucose intolerance 
 Presence of gestational diabetes (GDM) 
 Multiple pregnancy  
 Major vaginal bleeding 
 Hypertension 
 Preeclampsia 
 Urinary tract infection 
 Fetal-placental abnormalities (such as congenital anomalies) 
 Placenta previa and/or placental abruption 
 Nephropathy and/or liver disease 
 Current smoking and/or alcohol intake.  
The study was approved by an institutional ethical committee, functioning according to 
the 4th edition of the Guidelines on the Practice of Ethical Committees in Medical Research, 
issued by the Royal College of Physicians of London (Royal College of Physicians, 2007). 
We obtained full informed consent from each recruited pregnant woman, following detailed 
explanation of the purpose and nature of the research protocol. 
2.2. Protocol 
 Recruited women were seen once during each of the 2nd and 3rd trimesters of their 
pregnancy between 24 th-26 th and 34 th-36 th week of gestation, respectively. Recruited women 
received basic dietetic advice at their initial visit, without regular dietetic follow up. At each 
study visit, recruited women underwent anthropometric measurements that included fasting 
blood sampling at 8 am (assessment of serum CRH, cortisol and IL6) and a 75-gram oral 
glucose tolerance test (OGTT), with blood samples drawn at 0, 30, 60, 90 and 120 min time-
points for assessment of plasma glucose and insulin concentrations. At each study visit, 
recruited women also had a pelvic ultrasound assessment and self-completed a STAI trait and 
state questionnaire. Application of diagnostic criteria set by WHO (based on OGTT) for 
diagnosis of GDM (World Health Organization, 2013), resulted in exclusion of n=8 women 
from the study. The study cohort therefore had n=192 pregnant women (age and pre-
pregnancy BMI: 27.94.2 years and 26.9±2.4 kg/m², respectively, Table 1). Neonates 
underwent measurements of birth weight at birth, and waist circumference on the 3rd post-
partum day. We collected all blood (including cord blood) samples for measurement of 
hormones (cortisol, c peptide and insulin) and glucose in EDTA tubes. We added millipore’s 
serine protease inhibitor to each blood sample following its collection, followed by multiple 
tube inversion and immediate centrifugation. Following centrifugation, we collected plasma 
from each sample, and stored these as aliquots at –70°C. 
2.3. Stress Questionnaires 
 STAI trait and state self-rate questionnaires are composed of 20 questions each. The 
former provides data on trait characteristics of the subject, including how the individual 
usually feels.  The latter provides data on how the subject feels at the specific time of 
completion of the questionnaire.  
2.4. Anthropometrics and blood pressure measurements   
 A single observer executed anthropometric assessments of pregnant women. At pre-
pregnancy and at each study visit, we measured weight and height (the former without shoes 
and light clothing in kilograms to the nearest 0.1 kg on a beam balance; the latter to the 
nearest mm using a stadiometer). BMI in kg/m2 was calculated. Blood pressure was measured 
twice (mean value calculated) following sitting for 10 minutes and a 5-minute duration 
between measurements. We measured birthweight in kilograms with a portable digital 
electronic scale (Seca GMBH and Co. kg Germany, model 834), accurate to the nearest 10 
grams, without clothing or diapers. We measured neonatal waist circumference using a 
measuring tape at the umbilical level. 
2.5. Fetal ultrasound measurements 
 During ultrasonography, a single observer recorded fetal measurements (estimated 
weight, abdominal circumference, head circumference and biparietal diameter). We employed 
a Philips HD11 ultrasonographer to perform all ultrasonography. 
2.6. Blood chemistry and hormone assays  
 We measured all analytes in maternal sera and cord blood using the same 
methodology for both types of samples. We measured plasma glucose concentrations using 
the Roche Cobas 6000 Clinical Chemistry System (Roche Diagnostics Rotkreuz, CH). We 
measured serum insulin, cortisol and C-peptide concentrations with 
electrochemiluminescence immunoassays, using the Roche Cobas e411 immunochemistry 
analyzer (Roche Diagnostics Rotkreuz, CH).  Serum IL-6 was measured by the quantitative 
sandwich enzyme immunoassay technique (Quantikine, R&D Systems, Minneapolis, MN, 
USA) with the intra- and inter- assay CVs ranging between 6.9 and 7.4% and between 6.5 and 
9.6%, respectively. Serum CRH was measured by a quantitative kit based on the principle of 
“competitive” enzyme immunoassay (Phoenix Pharmaceuticals, Inc, Burlingame, CA, USA) 
with intra- and inter- assay CVs at <10% and <12%, respectively, according to the 
manufacturer.  
2.7. Statistical analysis  
We present data as mean  SD or median and interquartile range (25th-75th percentile) 
for data normally and non-normally distributed, respectively. To analyse the change of each 
variable during pregnancy, we used the one-way repeated measures ANOVA test for 
normally distributed variables, and the non-parametric Friedman ANOVA test for non-
normally distributed variables. For assessment of correlations between different variables, we 
performed Spearman correlation analyses. Stepwise multiple regression analysis was used to 
define 2nd and 3rd trimester predictive variables. A p-value of <0.05 was considered to be 
significant. We used the SPSS statistical software for statistical analysis (SPSS Inc., 1999).  
3. Results 
3.1. Anthropometric, hormonal, metabolic and psychometric variables  
Maternal weight increased significantly between each trimester (p<0.05), with a 
median increase of 11.5 kg between the 1st and 3rd trimester. Maternal systolic blood pressure 
values increased significantly from the 2nd to the 3rd trimester. Maternal fasting serum cortisol 
and CRH concentrations increased significantly from the 2nd to the 3rd trimester, whilst serum 
IL6 concentrations did not. STAI state scores showed a statistically significant increase from 
the 2nd to the 3rd trimester, whilst STAI trait scores remained static. Ultrasound-based fetal 
measurements of estimated weight, abdominal circumference, head circumference and 
biparietal diameter increased significantly from the 2nd to the 3rd trimester. Neonatal birth 
weight values were within normalcy (Table 1). 
In the 2nd and 3rd trimesters, women with STAI trait scores ≥40 had significantly 
greater serum fasting CRH levels (2.3 ±0.3 ng/ml and 2.8±0.2 ng/ml respectively), than those 
with STAI trait scores <40 (2.1±0.4 ng/ml and 2.6±0.5 ng/ml respectively; p<0.001 and 
p<0.001 respectively). In the 2nd and 3rd trimesters, women with STAI trait scores ≥40 had 
significantly greater fasting serum cortisol levels (25±7.2 μg/dL and 31±7.9 μg/dL 
respectively), than those with STAI trait scores <40 (20±7.6 μg/dL and 26±7.3 μg/dL 
respectively; p<0.001 and p<0.001 respectively).  
In the 3rd trimester, fetuses of women with STAI state scores ≥40 had larger 
abdominal and smaller head circumferences compared to those of women with STAI state 
scores <40. There was no difference in neonatal birth weight in these two groups of women 
(Table 2). 
In the 3rd trimester, women with STAI trait scores ≥40 had significantly greater levels 
of cord blood cortisol, glucose and c-peptide compared to women with STAI trait scores <40 
(Table 3).  
 
3.2. Correlations of maternal serum IL6, CRH and cortisol concentrations with fetal 
ultrasound measurements, birth waist circumference, and cord blood glucose, insulin, c-
peptide and cortisol concentrations 
2nd trimester: Maternal serum CRH concentrations correlated positively with maternal serum 
cortisol concentrations (p=0.038, r=0.328), and negatively with ultrasound-measured fetal 
biparietal head diameter (p=0.039, r=-0.357). Maternal serum cortisol concentrations 
correlated positively with ultrasound measured fetal abdominal circumference (p=0.030, 
r=0.823). Maternal serum IL6, CRH and cortisol concentrations all correlated positively with 
birth waist circumference (p=0.038, r=0.527; p=0.032, r=0.800 and p=0.034, r=0.790 
respectively. Table 4|). 
3rd trimester: Maternal serum CRH concentrations correlated positively with maternal serum 
cortisol concentrations (p=0.042, r=0.301), ultrasound-measured fetal abdominal 
circumference (p=0.031, r=0.396) and cord blood cortisol concentrations (p=0.029, r=0.589). 
Maternal serum IL6 and CRH concentrations both correlated negatively with fetal head 
circumference (p=0.001, r=-0.865; p=0.033, r=-0.385 respectively), and fetal biparietal head 
diameter measurements (p=0.013, r=-0.695; p=0.032, r=-0.355 respectively). Maternal serum 
CRH and cortisol concentrations both correlated positively with levels of cord blood c-peptide 
(p=0.022, r=0.684; p=0.026, r=0.614 respectively), glucose (p=0.027, r=0.655; p=0.035, 
r=0.515 respectively. Figure 1), and insulin (p=0.024, r=0.679; p=0.023, r=0.586 respectively. 
Table 5). 
 
3.3. Correlations of maternal psychometric variables (STAI state and trait 
questionnaires) with fetal ultrasound measurements and cord blood glucose, insulin, c-
peptide and cortisol concentrations 
2nd trimester: Maternal STAI state scores correlated positively with maternal CRH 
concentrations (p=0.044, r=0.455). STAI trait scores correlated positively with cord blood 
glucose (p=0.042, r=0.618) and c-peptide (p=0.041, r=0.589) concentrations (Table 4).  
3rd trimester: Maternal STAI state scores ≥40 correlated positively with maternal CRH 
concentrations (p=0.020, r=0.817) and ultrasound measured fetal abdominal circumference 
(p=0.024, r=0.548), and negatively with measurements of fetal head circumference (p=0.027, 
r=-0.362) and fetal biparietal diameter (p=0.009, r=-0.534). Maternal STAI trait scores 
correlated positively with levels of cord blood c-peptide (p=0.032, r=0.524), glucose 
(p=0.035, r=0.512), insulin (p=0.033, r=0.517) and cortisol (p=0.035, r=0.505. Table 5).  
 
  3.4. Predictors of fetal hormonal profile and growth patterns  
 In the 2nd trimester, multiple regression analysis showed that maternal serum cortisol 
concentrations were the best positive predictors of ultrasound measured fetal abdominal 
circumference (p=0.018, beta=0.782), with maternal serum levels of IL6, CRH and cortisol, 
maternal weight and maternal STAI state and trait scores all taken as independent variables.  
 In the 3rd trimester, multiple regression analysis showed that maternal STAI trait 
scores were the best positive predictors of levels of cord blood cortisol (p=0.035, beta=0.678), 
glucose (p=0.039, beta=0.601) and c-peptide (p=0.003, beta=1.085), with maternal serum 
IL6, CRH and cortisol concentrations, maternal weight, and STAI state and trait scores all 
taken as independent variables.  
 In the 3rd trimester, multiple regression analysis showed that maternal STAI state 
scores were the best positive predictors of ultrasound measured fetal abdominal 
circumference (p=0.021, beta=0.778). Maternal STAI state scores were also the best negative 
predictors of ultrasound measured fetal head circumference (p=0.032, beta=-0.723) and 
biparietal diameter (p=-0.009, beta=-0.965), with maternal serum IL6, CRH and cortisol 




 We demonstrate that in normal weight pregnant women, maternal STAI state scores 
and fasting serum levels of CRH and cortisol concentrations increase from the 2nd to the 3rd 
trimester. In the 2nd trimester, maternal serum CRH concentrations correlate positively with 
maternal STAI state scores and maternal serum cortisol concentrations, whilst in the 3rd 
trimester, maternal serum CRH concentrations correlate positively with maternal STAI state 
scores ≥40 and maternal serum cortisol concentrations. These findings are in accordance with 
previously published findings (Valsamakis G et al., 2017). Levels of placental CRH and 
maternal serum cortisol increase during pregnancy, and reflect maternal acute stress as scored 
subjectively by STAI state questionnaire. Stress-related stimulation of the maternal 
sympathetic nervous system can lead to enhanced placental CRH secretion via a reduction of 
uterine blood flow and placental hypo-perfusion (Texeira et al., 1979; Jones et al., 1989). We 
also demonstrate that in the 3rd trimester, women with STAI trait scores ≥40 have greater 
levels of serum cortisol and cord blood cortisol, compared to women with STAI trait scores 
<40. This suggests that maternal chronic stress (as reflected by higher STAI trait scores) 
associates with increased levels of cortisol both within the maternal and fetal circulations. We 
confirmed these observations with 3rd trimester STAI trait scores as the best positive predictor 
of levels of cord blood cortisol, and positive correlations between 3rd trimester STAI trait 
scores and placenta-derived CRH concentrations with levels of cord blood cortisol.  
In a recently reported study of normal pregnancies in the 3rd trimester, maternal 
pregnancy-specific stress assessed by the Prenatal Distress Questionnaire (PDQ, a 12-item 
scale), had a positive association with levels of neonatal hair cortisol, a marker of fetal 
cortisol concentrations during pregnancy (Romero-Gonzalez et al., 2018). During pregnancy, 
stress-induced increased levels of maternal serum cortisol may cross the placenta by 
overwhelming the protective placental barrier of 11βHSD2 action (Rakers et al., 2017; 
Konstantakou et al., 2017). In contrast to the inhibitory effect of cortisol on hypothalamic 
CRH production, maternal cortisol stimulates placental CRH production. This positive 
feedback loop, in turn stimulates the fetal HPA axis resulting in increased levels of fetal 
cortisol (Glover et al., 2009). Thus, chronic maternal stress and elevated levels of placental 
CRH result in increased levels of neonatal cortisol, and may induce epigenetic changes in the 
offspring’s HPA function. However, in one study on pregnancy outcomes following the 
effects of acute stress experienced during the 9/11 events, offspring had reduced levels of 
serum cortisol (Yehuda et al., 2005). Thus, re-programming effects of maternal stress on the 
offspring’s HPA axis may manifest differential translation depending on the amplitude and 
type of stressor, and the timing of exposure to it as previously suggested, resulting in either 
increased or decreased baseline cortisol production in the offspring (Romero-Gonzalez et al., 
2018). Existing data imply that there could exist a transgenerational manifestation of maternal 
stress inheritance into the fetus, and further studies are required to examine this evidence 
(Glover et al., 2009; Van den Bergh et al., 2017). 
 In the 3rd trimester, maternal STAI trait scores, serum CRH and cortisol 
concentrations correlated positively with cord blood c-peptide, glucose and insulin 
concentrations. Furthermore, women with STAI trait scores ≥40 in the 3rd trimester showed 
significantly greater cord blood c-peptide and glucose concentrations compared to those with 
STAI trait scores <40. Thus, it appears that chronic maternal stress associates with increased 
cord blood glucose, c-peptide and insulin concentrations, all markers of fetal 
hyperinsulinemia and insulin resistance. It seems that chronic (STAI trait) and not acute 
(STAI state) maternal stress associates with development of fetal hyperinsulinemia. Of note, 
cord blood measurements reflect fetal metabolism at birth (Martin et al., 2015). Maternal 
stress-associated increase of fetal cortisol, glucose and insulin concentrations suggests that 
maternal stress relates to development of fetal insulin resistance. These results should be 
corroborated with a study of the offspring of Holocaust survivors and controls of non-exposed 
mothers, concluding that the former showed a higher risk for having two or more metabolic 
syndrome conditions (e.g., hypertension, dyslipidemia, type 2 diabetes, and overweight) 
compared to the latter (Flory et al., 2011). In addition, in a large epidemiological study, 
maternal bereavement from death of someone close during pregnancy was shown to associate 
with an increased risk of overweight and type 2 diabetes in offspring during later childhood 
(Li et al., 2010; Dreilling et al., 2018; Brunton et al., 2013). Furthermore, maternal prenatal 
stress associates with stress-induced hyperglycemia in male but not female rat offspring, 
whilst hyperinsulinemia was noted in response to glucose loading in female but not male 
offspring, implying a sexually-dimorphic effect in rat offspring in response to maternal stress 
(Brunton et al., 2013; Qian et al., 2015).  
 In our study, we demonstrate that during the 2nd trimester, maternal serum CRH and 
cortisol concentrations correlate negatively and positively with ultrasound measurements of 
fetal biparietal diameter and abdominal circumference respectively. Also in the 2nd trimester, 
maternal cortisol concentrations were the best positive predictors of ultrasound measured fetal 
abdominal circumference amongst maternal serum levels of IL6, CRH and cortisol, maternal 
weight and STAI state and trait scores. Maternal serum IL6, CRH, and cortisol concentrations 
correlated positively with birth waist circumference. In the 3rd trimester, maternal STAI state 
scores, serum CRH and IL6 concentrations correlated negatively with ultrasound measures of 
biparietal diameter and head circumference, whilst STAI state scores and maternal serum 
CRH concentrations correlated positively with abdominal circumference.  Women with STAI 
state scores ≥40 in the 3rd trimester had babies with greater ultrasound measures of abdominal 
circumference and smaller ultrasound measures of head circumference compared to those 
with STAI state scores <40. Notably, maternal STAI state score during the 3rd trimester was 
the best positive predictor of ultrasound measures of abdominal circumference, and the best 
negative predictor of fetal head circumference and biparietal diameter. During pregnancy, a 
relative placental CRH-derived maternal hypercortisolemia develops from the 2nd trimester 
until birth. Thus, it appears that increased maternal acute stress (reflected by STAI state score) 
during the 3rd trimester of normal pregnancies, associates with increased measures of fetal 
abdominal circumference and decreased measures of fetal head circumference, indicating that 
maternal stress evaluated by subjective and objective markers during normal pregnancy 
affects fetal development. Maternal stress results in increased levels of serum cortisol, that in 
turn affects the fetus by overriding placental 11β-hydroxysteroid-dehydrogenase type 2 
(Konstantakou et al., 2017; Yehuda et al., 2005; Rakers et al., 2015). This could have 
detrimental effects on fetal cell proliferation, differentiation and synapse formation, mainly in 
amygdala, hippocampus and limbic cortical areas with short- and long- term postnatal 
consequences (Monteleone et al., 2014; Barros et al., 2006).  
In one recent reported study on pregnant women, increased levels of maternal serum 
IL-6 and diurnal salivary alpha amylase (both markers of stress), were both associated 
negatively with head circumference at birth and positively with birthweight (Nazzari et al., 
2019). In a further study on 2.6 million pregnancies in a Swedish population, the risk for low 
birth weight and small for gestational age fetuses was greater following acute stress exposure 
during the 2nd trimester of pregnancy (Class et al., 2011). A meta-analysis of 35 studies 
between 1991 and 2009 involving 31,323 women revealed a small, non-negligible, positive 
association between maternal psychosocial stress during pregnancy and risk for low 
birthweight (Littleton et al., 2010). It seems likely that the timing of maternal stress exposure 
during pregnancy could be an important factor that influences effects on fetal development. 
Taken together, our data suggest that greater acute maternal stress scores in the 3rd trimester 
of normal pregnancy affect fetal growth symmetry, by contributing directly and/or indirectly 
to decreased head circumference and increased abdominal circumference and birth waist 
circumference. 
  In our non-obese non-diabetic cohort of pregnant women, maternal chronic stress 
associated with increased fetal serum cortisol and insulin secretion (hyperinsulinemia). 
Maternal acute stress in the 3rd trimester associated with changes in fetal growth pattern 
including increased abdominal growth and decreased head growth. By influencing fetal 
growth and metabolism, maternal acute and chronic stress during pregnancy might predispose 
the fetus to IUGR, and subsequent development of enhanced HPA axis activity and insulin 
resistance. These pathophysiological observations might explain why babies with IUGR 
manifest increased susceptibility to development of type 2 diabetes later in life (Valsamakis et 
al., 2006). Furthermore, hormonal changes observed in umbilical cord blood might lead to 
epigenetic alterations in the offspring, thereby influencing fetal endocrine programming and 
brain development potentially across several generations (Stokes et al., 2012).  
 
4.1. Conclusion 
   In conclusion, our study shows clear association between maternal acute- and long-
term stress with patterns of fetal growth and metabolism. Chronic maternal stress seems to 
increase fetal cortisol, glucose, insulin, and c-peptide secretion, reflecting enhanced fetal 
insulin resistance. Further studies are required to elucidate the underlying pathophysiological 
mechanisms and interactions of maternal stress experienced during pregnancy, and the 
potential for epigenetic effects on future generations, through trans-generational 
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Legend to the Figure 
Figure 1: Correlation between cord blood glucose and maternal CRH concentrations 
in the 3rd trimester (p=0.027, r=0.655). 
Table 1: Maternal anthropometric, hormone, metabolic and psychometric variables 
during pregnancy. Variables are expressed as mean (±SD) or median (25th–75th 
interquartile range); the asterisk (*) denotes statistically significant difference from 
the 1st trimester (P<0.05); (≠) denotes statistically significant difference (P<0.05) from 
the 2nd trimester. 
Νumber of pregnancies 192 
MATERNAL VALUES 
Pre-pregnancy BMI (kg/m²) 26.9±2.4  
PREGNANCY 1st trimester 2nd trimester 3rd trimester 
Weight (kg) 66 (±12.8) 70 (±12.7)* 79 (±14) * # 
Systolic Blood pressure 
(mmHg) 
 107 (±12) 114 (±12)# 
CRH (ng/ml)  2.2 (±0.4) 2.7 (±0.25)# 
Cortisol (μg/dL)  22.2 (±6.7) 28 (±7.3) # 
IL6 (ng/L)  1.9 (1.1-4) 1.6 (1.2-1.9) 
STAI state  33.9 (±6.8) 40.34 (±6.65)# 
STAI trait  39.6 (±8.4) 34.9 (±8.7) 
 
FETAL VALUES 
US abdomen circumference 
(mm) 
 191.9 (±19.6) 289 (±22.3)# 
US head circumference (mm)  218.6 (±20.7) 308.5 (±14.9)# 
US estimated weight (gr)  650 (503–815) 2,270 (1,800–
2,413)# 
US biparietal diameter (mm)  58.6(±5.1) 84.3 (±5.4) # 
 
NEONATAL VALUES  





Birth waist (cm) 
Cord cortisol (μg/dL) 
Cord insulin (pmol/L) 
Cord glucose (mg/dL) 
Cord c-peptide (nmol/L) 0.8 (0.3) 
 
Table 2: Comparison of fetal U/S measured and neonatal anthropometric parameters  
according to maternal STAI state scores in the 3rd trimester (high: ≥40; low: <40). 
 State<40 State ≥40 p-value 
State score 30.6 (±4.01) 42.8 (±3.04) 0.034 
US head 
circumference (mm) 
315.3 (±7.2) 298.2 (±6.9) 0.023 
U/S abdominal 
circumference (mm) 
277.8 (±9.9) 301 (±10.6) 0.027 





Table 3: Comparison of fetal cord blood glucose, c-peptide and cortisol according to 
maternal STAI trait score in the 3rd trimester (high: ≥40; low: <40). 
 Trait<40 Trait≥40 p-value 
Trait score 32 (±5.6) 45.2 (±5) 0.032 
Cord blood cortisol 
(μg/dL) 
10 (±7.8) 15.1 (±8.6) 0.035 
Cord blood glucose 
(mg/dL) 
94 (±5.3) 103 (±6.4)  0.029 
Cord blood c-peptide 
(nmol/L) 
0.65 (0.15) 0.95 (0.15) 0.021 
 
 
Table 4. Correlations between maternal IL6, CRH and cortisol concentrations and 
psychometric variables (STAI state and trait scores) with fetal ultrasonographic 
measurements in the 2nd trimester, birth waist, as well as with cord blood glucose, 







STAI trait STAI state 
Maternal 
CRH 
     0.455 
Maternal 
cortisol 
 0.328    
Fetal US 
abdo 
  0.823   
Fetal US 
BPD 
 -0.357    
Birth waist 0.527 0.800               0.790                    
Cord blood 
glucose 
   0.618  
Cord blood 
c-peptide 











Table 5. Correlations between maternal IL6, CRH and cortisol concentrations and 
psychometric variables (STAI state and trait scores) with fetal ultrasonographic 
measurements in the 3rd trimester, as well as with cord blood glucose, insulin, c-














Maternal CRH     r = 
0.817 
 
Fetal US abdo 
circumference 
 0.396  0.548   
Fetal US head 
circumference 
-0.865 -0.385  -0.362   
Fetal US BPD -0.695 -0.355  -0.534   
Cord blood 
glucose 
 0.655 0.515   0.512 
Cord blood 
insulin 
 0.679 0.586   0.517 
Cord blood c-
peptide 
 0.684 0.614   0.524 
Cord blood 
cortisol  
 0.589    0.505 
                                     
Figure 1 
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